Refine
Has Fulltext
- yes (63)
Is part of the Bibliography
- yes (63)
Year of publication
Document Type
- Journal article (63)
Keywords
- osteoarthritis (5)
- knee (4)
- MSCs (3)
- tissue engineering (3)
- total hip arthroplasty (3)
- total knee arthroplasty (3)
- tranexamic acid (3)
- vitamin D (3)
- AMADEUS (2)
- COVID-19 (2)
- Germany (2)
- Medizin (2)
- TKA (2)
- cartilage (2)
- cartilage regeneration (2)
- chondrocytes (2)
- direct anterior approach (2)
- implant positioning (2)
- knee arthroplasty (2)
- knee osteoarthritis (2)
- knee replacement (2)
- mechanotransduction (2)
- mesenchymal stromal cells (2)
- patient-specific (2)
- periprosthetic infection (2)
- periprosthetic joint infection (2)
- prospective study (2)
- revision arthroplasty (2)
- scaffolds (2)
- spacer (2)
- stem cells (2)
- total joint arthroplasty (2)
- two-stage exchange (2)
- 3D models (1)
- 3D organoids (1)
- Anatomic reattachment (1)
- Aseptic loosening (1)
- Bone marrow (1)
- Bone tumor (1)
- CYP24A1 (1)
- Cartilage regeneration (1)
- Case report (1)
- Chondrosarcoma (1)
- Copal\(^®\) spacem (1)
- Desmoplastic fibroma (1)
- Distal biceps tendon repair (1)
- Fraktur (1)
- Glenohumeralgelenk (1)
- Hip joint (1)
- Hueter interval (1)
- ICRS (1)
- Joint capsule (1)
- KOOS (1)
- Ligamentum capitis femoris (1)
- MPFL (1)
- MRI (1)
- Non-simultaneous bilateral distal biceps tendon rupture (1)
- Osteoarthritis (1)
- Osteoporose (1)
- Osteosynthese (1)
- PMMA (1)
- PMMA bone cement (1)
- PROM (1)
- Paprosky (1)
- Schulterendoprothetik (1)
- Soft-tissue sarcoma (1)
- Staphylococcus aureus / drug effects (1)
- Suture anchor (1)
- Synovial Fluid Aspiration (1)
- Tissue engineering (1)
- Total knee arthroplasty (1)
- VDR (1)
- Vancomycin / administration & dosage (1)
- Vancomycin / chemistry (1)
- Vancomycin / pharmacology (1)
- acetabular bone defect (1)
- acetabular bone defects (1)
- age and gender analysis (1)
- age distribution (1)
- algorithm (1)
- anatomic center of rotation (1)
- anatomical landmark (1)
- anterior approach (1)
- anti-bacterial agents / administration & dosage (1)
- anti-bacterial agents / chemistry (1)
- anti-bacterial agents / pharmacology (1)
- antibiotic elution (1)
- apoptosis (1)
- approach (1)
- aseptic loosening (1)
- asymmetric implant (1)
- autograft (1)
- autologous chondrocyte implantation (1)
- autophagy (1)
- axial alignment (1)
- benige tumor (1)
- benign bone tumor (1)
- bi-compartmental (1)
- bi-compartmental knee arthoplasty (1)
- biocompatible Materials (1)
- biomaterials – cells (1)
- bone (1)
- bone cement (1)
- bone marrow edema (1)
- bone metastasis (1)
- bone model (1)
- bone tissue engineering (1)
- bone tumour (1)
- bone wires (1)
- calcification (1)
- cartilage defect (1)
- cartilage defects (1)
- cartilage surgery (1)
- case report (1)
- cell-based therapies (1)
- cell-matrix interaction (1)
- cellular origin (1)
- chondral defect (1)
- chondrogenic differentiation (1)
- click chemistry (1)
- clinical outcome (1)
- colony-stimulating factor (1)
- compressive load (1)
- compressive strength (1)
- computer navigation (1)
- consensus (1)
- core depression (1)
- correlation (1)
- curettage (1)
- custom made implant (1)
- custom-made implant (1)
- decellularization (1)
- defects (1)
- dermal fibroblasts (1)
- dexamethasone (1)
- differentiation capacity (1)
- drain (1)
- drug liberation (1)
- elution (1)
- epidemiological analysis (1)
- extracellular vesicles (1)
- fast track rehabilitation (1)
- fast-track-concepts (1)
- fibrin (1)
- fluid simulation (1)
- foot and ankle procedures (1)
- fracture incidence (1)
- fragility fractures (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- germanophone (1)
- glycocalyx (1)
- grading system of chondral defects (1)
- hMSC-TERT (1)
- hMSCs (1)
- haemoglobin (1)
- handball (1)
- hematoma (1)
- high tibial osteotomy (1)
- high tibial valgus osteotomy (1)
- hip (1)
- hip joint (1)
- hip replacement (1)
- human trabecular bone decellularization (1)
- hydrogels (1)
- hypovitaminosis D (1)
- iTotal (1)
- immunomodulation (1)
- immunotherapy (1)
- implant fit (1)
- in situ guided tissue regeneration (1)
- in vitro (1)
- in vitro modeling (1)
- inbound medical tourism (1)
- inpatient rehabilitation (1)
- interstage aspiration (1)
- joint aspiration (1)
- knee alignment (1)
- knee axis (1)
- knee joint (1)
- knee rotator cuff (1)
- level of evidence III (1)
- linear regression (1)
- lower extremity (1)
- lower extremity amputation (1)
- major amputation (1)
- malignancy (1)
- materials testing (1)
- mayo stem (1)
- mechanical alignment (1)
- mechanosensing (1)
- medial patellofemoral ligament (1)
- medical collateral ligament (1)
- mesenchymal cells (1)
- mesenchymal tissues (1)
- metabolic glycoengineering (1)
- metabolism (1)
- microbiological culture (1)
- minimal invasive surgery (1)
- minimally invasive (1)
- minimally invasive surgery (1)
- minimally-invasive (1)
- minor amputation (1)
- modified monosaccharides (1)
- multicomponent stretching (1)
- muscle (1)
- musculoskeletal sarcoma (1)
- myokines (1)
- open surgical repair (1)
- orthopaedic surgery (1)
- orthopaedics (1)
- orthopedic surgery (1)
- osteochondral allografts (1)
- osteogenesis (1)
- osteogenesis imperfecta (1)
- osteokines adaptation (1)
- pandemic (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- patient blood management (1)
- patient reported outcome measures (1)
- patient specific implant (1)
- patient-specific knee arthroplasty (1)
- pelvic discontinuity (1)
- perforator (1)
- perioperative management (1)
- personalised orthopaedic implantation (1)
- phenotype (1)
- platelet-rich plasma (1)
- polymethylmethacrylate (1)
- posterior tibial slope (1)
- postoperative Komplikationen (1)
- postoperative rehabilitation (1)
- pre- and post-outbreak comparison (1)
- progenitor cells (1)
- prostheses and implants (1)
- quantification (1)
- rare bone tumor (1)
- regenerative capacity (1)
- regenerative medicine (1)
- regenerative therapies (1)
- regional transient osteoporosis (1)
- repair (1)
- revision hip (1)
- robotic (1)
- scaffold-free (1)
- scientific publications (1)
- scoping review (1)
- segmental collapse (1)
- senescence (1)
- senescence‐associated secretory phenotype (1)
- septic (1)
- shear stress (1)
- sheep model (1)
- short hip stem (1)
- shoulder injuries (1)
- statistical shape model (1)
- stem cell niche (1)
- stemness (1)
- stimulation (1)
- stromal cells (1)
- sutures (1)
- tendon tissue engineering (1)
- tenogenic differentiation (1)
- therapy (1)
- total knee replacement (1)
- toxicity (1)
- transgluteal approach (1)
- translational research (1)
- transplantation (1)
- triangle method (1)
- tricompartmental knee osteoarthritis (1)
- trochlear dysplasia (1)
- tumour malignancy (1)
- vitamin C (1)
- vitamin D deficiency (1)
- vitamin D receptor (1)
- volume analysis (1)
- weight bearing line (1)
- white blood cell count (1)
Institute
- Lehrstuhl für Orthopädie (63)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (6)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (4)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (3)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Medizinische Klinik und Poliklinik II (2)
- Pathologisches Institut (2)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Hygiene und Mikrobiologie (1)
Sonstige beteiligte Institutionen
The treatment landscape in multiple myeloma (MM) is shifting from genotoxic drugs to immunotherapies. Monoclonal antibodies, immunoconjugates, T-cell engaging antibodies and CART cells have been incorporated into routine treatment algorithms, resulting in improved response rates. Nevertheless, patients continue to relapse and the underlying mechanisms of resistance remain poorly understood. While Impaired death receptor signaling has been reported to mediate resistance to CART in acute lymphoblastic leukemia, this mechanism yet remains to be elucidated in context of novel immunotherapies for MM. Here, we describe impaired death receptor signaling as a novel mechanism of resistance to T-cell mediated immunotherapies in MM. This resistance seems exclusive to novel immunotherapies while sensitivity to conventional anti-tumor therapies being preserved in vitro. As a proof of concept, we present a confirmatory clinical case indicating that the FADD/BID axis is required for meaningful responses to novel immunotherapies thus we report impaired death receptor signaling as a novel resistance mechanism to T-cell mediated immunotherapy in MM.
In vitro co-cultures of different primary human cell types are pivotal for the testing and evaluation of biomaterials under conditions that are closer to the human in vivo situation. Especially co-cultures of macrophages and mesenchymal stem cells (MSCs) are of interest, as they are both present and involved in tissue regeneration and inflammatory reactions and play crucial roles in the immediate inflammatory reactions and the onset of regenerative processes, thus reflecting the decisive early phase of biomaterial contact with the host. A co-culture system of these cell types might thus allow for the assessment of the biocompatibility of biomaterials. The establishment of such a co-culture is challenging due to the different in vitro cell culture conditions. For human macrophages, medium is usually supplemented with human serum (hS), whereas hMSC culture is mostly performed using fetal calf serum (FCS), and these conditions are disadvantageous for the respective other cell type. We demonstrate that human platelet lysate (hPL) can replace hS in macrophage cultivation and appears to be the best option for co-cultivation of human macrophages with hMSCs. In contrast to FCS and hS, hPL maintained the phenotype of both cell types, comparable to that of their respective standard culture serum, as well as the percentage of each cell population. Moreover, the expression profile and phagocytosis activity of macrophages was similar to hS.
Introduction
The goals of successful bi-compartmental knee arthroplasty are to achieve correct fit and positioning of the implant, while appropriately correcting the mechanical alignment of the leg after surgery. As these requirements are not always reliably fulfilled using off-the-shelf implant systems, newer approaches for bi-compartmental resurfacing have been explored.
Material and methods
In this article we report the radiographic results of 30 patients with anteromedial osteoarthritis (OA) who were treated with a novel patient-specific fixed-bearing bi-compartmental knee resurfacing system using custom-made implants and instruments. Utilizing standardized pre- and postoperative radiographic analyses (based on anterior-posterior and lateral, anterior-posterior weight-bearing full-length radiographs, patella skyline views and preoperative computed tomography (CT) scanning) implant fit and positioning as well as correction of the mechanical axis (hip-knee-ankle angle, HKA) were determined.
Results
On average, HKA was corrected from 173.4 ±3.47° preoperatively to 179.4 ±2.85° postoperatively. The coronal femoro-tibial angle was corrected on average 5.61°. The preoperative tibial slope measured on lateral views was 6.38 ±2.4°, while the average slope in the CT-based planning protocol (iView) was 6.14 ±2.40°. Postoperative lateral tibial slope was determined to be 5.77 ±1.97°. The thickness of the posterior femoral cuts was measured intraoperatively and, in all cases, corresponded well to the targeted thickness of the cuts provided by the iView. The joint line was preserved in all cases and the average Insall-Salvati index was 1.078 ±0.11 pre- and 1.072 ±0.11 postoperatively. The fit of the implant components measured by over- or underhang was excellent throughout (< 1.01 mm).
Conclusions
Custom-made bicompartmental knee arthroplasty can ensure optimized fitting and positioning of the implant with restoration of the leg axis. These implants could be considered as an alternative primary solution for knee surgeons treating bi-compartmental disease.
Calcification of the medial collateral ligament (MCL) of the knee is a very rare disease. We report on a case of a patient with a calcifying lesion within the MCL and simultaneous calcifying tendinitis of the rotator cuff in both shoulders. Case presentation: Calcification of the MCL was diagnosed both via x-ray and magnetic resonance imaging (MRI) and was successfully treated surgically. Calcifying tendinitis of the rotator cuff was successfully treated applying conservative methods. Conclusion: This is the first case report of a patient suffering from both a calcifying lesion within the medial collateral ligament and calcifying tendinitis of the rotator cuff in both shoulders. Clinical symptoms, radio-morphological characteristics and macroscopic features were very similar and therefore it can be postulated that the underlying pathophysiology is the same in both diseases. Our experience suggests that magnetic resonance imaging and x-ray are invaluable tools for the diagnosis of this inflammatory calcifying disease of the ligament, and that surgical repair provides a good outcome if conservative treatment fails. It seems that calcification of the MCL is more likely to require surgery than calcifying tendinitis of the rotator cuff. However, the exact reason for this remains unclear to date.
Background
The key for successful delivery in minimally-invasive hip replacement lies in the exact knowledge about the surgical anatomy. The minimally-invasive direct anterior approach to the hip joint makes it necessary to clearly identify the tensor fasciae latae muscle in order to enter the Hueter interval without damaging the lateral femoral cutaneous nerve. However, due to the inherently restricted overview in minimally-invasive surgery, this can be difficult even for experienced surgeons.
Methods and Surgical Technique
In this technical note, we demonstrate for the first time how to use the tensor fasciae latae perforator as anatomical landmark to reliably identify the tensor fasciae latae muscle in orthopaedic surgery. Such perforators are used for flaps in plastic surgery as they are constant and can be found at the lateral third of the tensor fasciae latae muscle in a direct line from the anterior superior iliac spine.
Conclusion
As demonstrated in this article, a simple knowledge transfer between surgical disciplines can minimize the complication rate associated with minimally-invasive hip replacement.
Juvenile Dermatomyositis (JDM) is a rare autoimmune disease in children and adolescents. In these patients calcinosis might be the most characteristic symptom. However there are only few reported cases of intramuscular calcinosis in Dermatomyositis. We report a case of calcinosis universalis (CU) of the elbow in JDM successfully treated with broaching. The patient, a 24-year-old woman, suffered from a long history of JDM. On examination she presented with a fistula lateral to the olecranon and pain of the right elbow joint. Plain X-rays displayed a diffuse pattern of multiple periarticular, subcutaneous, and intramuscular calcifications. The patient underwent surgery for histological and microbiological sampling as well as broaching. Intraoperatively sinus formation and subfascial hard calcium deposition were found. Due to the risk of collateral tissue damage, incomplete broaching was performed. A local infection with Staphylococcus was diagnosed and treated with antibiotics. On six-week and 30-month follow-up the patient was free of pain and had very good function. Calcifications on standard radiographs had almost resolved entirely. This case report gives a summary on calcinosis in Dermatomyositis and adds a new case of recalcitrant CU to the literature. Broaching surgery proved to be a reliable treatment option in symptomatic calcinosis.
In situ guided tissue regeneration, also addressed as in situ tissue engineering or endogenous regeneration, has a great potential for population-wide “minimal invasive” applications. During the last two decades, tissue engineering has been developed with remarkable in vitro and preclinical success but still the number of applications in clinical routine is extremely small. Moreover, the vision of population-wide applications of ex vivo tissue engineered constructs based on cells, growth and differentiation factors and scaffolds, must probably be deemed unrealistic for economic and regulation-related issues. Hence, the progress made in this respect will be mostly applicable to a fraction of post-traumatic or post-surgery situations such as big tissue defects due to tumor manifestation. Minimally invasive procedures would probably qualify for a broader application and ideally would only require off the shelf standardized products without cells. Such products should mimic the microenvironment of regenerating tissues and make use of the endogenous tissue regeneration capacities. Functionally, the chemotaxis of regenerative cells, their amplification as a transient amplifying pool and their concerted differentiation and remodeling should be addressed. This is especially important because the main target populations for such applications are the elderly and diseased. The quality of regenerative cells is impaired in such organisms and high levels of inhibitors also interfere with regeneration and healing. In metabolic bone diseases like osteoporosis, it is already known that antagonists for inhibitors such as activin and sclerostin enhance bone formation. Implementing such strategies into applications for in situ guided tissue regeneration should greatly enhance the efficacy of tailored procedures in the future.
The topical application of tranexamic acid (TXA) helps to prevent post-operative blood loss in total joint replacements. Despite these findings, the effects on articular and periarticular tissues remain unclear. Therefore, this in vitro study examined the effects of varying exposure times and concentrations of TXA on proliferation rates, gene expression and differentiation capacity of chondrocytes and human mesenchymal stromal cells (hMSCs), which underwent osteogenic differentiation. Chondrocytes and hMSCs were isolated and multiplied in monolayer cell cultures. Osteogenic differentiation of hMSCs was induced for 21 days using a differentiation medium containing specific growth factors. Cell proliferation was analyzed using ATP assays. Effects of TXA on cell morphology were examined via light microscopy and histological staining, while expression levels of tissue-specific genes were measured using semiquantitative RT-PCR. After treatment with 50 mg/mL of TXA, a decrease in cell proliferation rates was observed. Furthermore, treatment with concentrations of 20 mg/mL of TXA for at least 48 h led to a visible detachment of chondrocytes. TXA treatment with 50 mg/mL for at least 24 h led to a decrease in the expression of specific marker genes in chondrocytes and osteogenically differentiated hMSCs. No significant effects were observed for concentrations beyond 20 mg/mL of TXA combined with exposure times of less than 24 h. This might therefore represent a safe limit for topical application in vivo. Further research regarding in vivo conditions and effects on hMSC functionality are necessary to fully determine the effects of TXA on articular and periarticular tissues.
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head
(2012)
Avascular necrosis (AVN) of the femoral head is a debilitating disease of multifactorial genesis, predominately affects young patients, and often leads to the development of secondary osteoarthritis. The evolving field of regenerative medicine offers promising treatment strategies using cells, biomaterial scaffolds, and bioactive factors, which might improve clinical outcome. Early stages of AVN with preserved structural integrity of the subchondral plate are accessible to retrograde surgical procedures, such as core decompression to reduce the intraosseous pressure and to induce bone remodeling. The additive application of concentrated bone marrow aspirates, ex vivo expanded mesenchymal stem cells, and osteogenic or angiogenic growth factors (or both) holds great potential to improve bone regeneration. In contrast, advanced stages of AVN with collapsed subchondral bone require an osteochondral reconstruction to preserve the physiological joint function. Analogously to strategies for osteochondral reconstruction in the knee, anterograde surgical techniques, such as osteochondral transplantation (mosaicplasty), matrix-based autologous chondrocyte implantation, or the use of acellular scaffolds alone, might preserve joint function and reduce the need for hip replacement. This review summarizes recent experimental accomplishments and initial clinical findings in the field of regenerative medicine which apply cells, growth factors, and matrices to address the clinical problem of AVN.
Adjuvant Radiotherapy
(2011)